| Year |
Citation |
Score |
| 2019 |
Klinngam W, Janga SR, Lee C, Ju Y, Yarber F, Shah M, Guo H, Wang D, MacKay JA, Edman MC, Hamm-Alvarez SF. Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren's Syndrome. Scientific Reports. 9: 9559. PMID 31267034 DOI: 10.1038/S41598-019-45966-7 |
0.69 |
|
| 2019 |
Shah M, Cabrera-Ghayouri S, Christie LA, Held KS, Viswanath V. Translational Preclinical Pharmacologic Disease Models for Ophthalmic Drug Development. Pharmaceutical Research. 36: 58. PMID 30805711 DOI: 10.1007/S11095-019-2588-5 |
0.336 |
|
| 2018 |
Guo H, Lee C, Shah M, Janga SR, Edman MC, Klinngam W, Hamm-Alvarez SF, Andrew Mackay J. A novel elastin-like polypeptide drug carrier for cyclosporine A improves tear flow in a mouse model of Sjögren's syndrome. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30359668 DOI: 10.1016/J.Jconrel.2018.10.026 |
0.728 |
|
| 2018 |
Janga SR, Shah M, Ju Y, Meng Z, Edman M, Hamm-Alvarez SF. Longitudinal Analysis of Tear Cathepsin S Activity Levels in Male Non-Obese Diabetic Mice Suggests its Potential as an Early Stage Biomarker of Sjögren's Syndrome. Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. 1-35. PMID 30126300 DOI: 10.1080/1354750X.2018.1514656 |
0.343 |
|
| 2018 |
Hawley D, Tang X, Zyrianova T, Shah M, Janga S, Letourneau A, Schicht M, Paulsen F, Hamm-Alvarez S, Makarenkova HP, Zoukhri D. Myoepithelial cell-driven acini contraction in response to oxytocin receptor stimulation is impaired in lacrimal glands of Sjögren's syndrome animal models. Scientific Reports. 8: 9919. PMID 29967327 DOI: 10.1038/S41598-018-28227-X |
0.341 |
|
| 2017 |
Shah M, Edman MC, Reddy Janga S, Yarber F, Meng Z, Klinngam W, Bushman J, Ma T, Liu S, Louie S, Mehta A, Ding C, MacKay JA, Hamm-Alvarez SF. Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome. Investigative Ophthalmology & Visual Science. 58: 372-385. PMID 28122086 DOI: 10.1167/Iovs.16-19159 |
0.587 |
|
| 2014 |
Hamm-Alvarez SF, Janga SR, Edman MC, Madrigal S, Shah M, Frousiakis SE, Renduchintala K, Zhu J, Bricel S, Silka K, Bach D, Heur M, Christianakis S, Arkfeld DG, Irvine J, et al. Tear cathepsin S as a candidate biomarker for Sjögren's syndrome. Arthritis & Rheumatology (Hoboken, N.J.). 66: 1872-81. PMID 24644101 DOI: 10.1002/Art.38633 |
0.331 |
|
| 2013 |
Shah M, Edman MC, Janga SR, Shi P, Dhandhukia J, Liu S, Louie SG, Rodgers K, Mackay JA, Hamm-Alvarez SF. A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjögren's syndrome. Journal of Controlled Release : Official Journal of the Controlled Release Society. 171: 269-79. PMID 23892265 DOI: 10.1016/J.Jconrel.2013.07.016 |
0.724 |
|
| 2013 |
Shi P, Aluri S, Lin YA, Shah M, Edman M, Dhandhukia J, Cui H, MacKay JA. Elastin-based protein polymer nanoparticles carrying drug at both corona and core suppress tumor growth in vivo. Journal of Controlled Release : Official Journal of the Controlled Release Society. 171: 330-8. PMID 23714121 DOI: 10.1016/J.Jconrel.2013.05.013 |
0.6 |
|
| 2012 |
Shah M, Hsueh PY, Sun G, Chang HY, Janib SM, MacKay JA. Biodegradation of elastin-like polypeptide nanoparticles. Protein Science : a Publication of the Protein Society. 21: 743-50. PMID 22434766 DOI: 10.1002/Pro.2063 |
0.728 |
|
| Show low-probability matches. |